The estimated Net Worth of George D Le Maitre is at least $44.3 millió dollars as of 8 August 2012. Mr. Maitre owns over 5,862 units of Lemaitre Vascular Inc stock worth over $41,968,956 and over the last 16 years he sold LMAT stock worth over $929,608. In addition, he makes $1,397,740 as Chairman of the Board és Chief Executive Officer at Lemaitre Vascular Inc.
Sign up
Mr. LeMaitre LMAT stock SEC Form 4 insiders trading
George has made over 6 trades of the Lemaitre Vascular Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 5,862 units of LMAT stock worth $37,810 on 8 August 2012.
The largest trade he's ever made was selling 80,000 units of Lemaitre Vascular Inc stock on 9 May 2011 worth over $554,400. On average, George trades about 7,909 units every 31 days since 2008. As of 8 August 2012 he still owns at least 483,792 units of Lemaitre Vascular Inc stock.
You can see the complete history of Mr. Maitre stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
George LeMaitre biography
George W. LeMaitre serves as Chairman of the Board, Chief Executive Officer of the Company. Previously, Mr. LeMaitre was an investment banking analyst at Lehman Brothers, an associate at the leveraged buyout firm McCown De Leeuw and a credit analyst for Connecticut National Bank. Mr. LeMaitre received a B.A. in History from Stanford University and an M.B.A. from the Stanford University Graduate School of Business. The Board has concluded that Mr. LeMaitre should serve on our Board due to his extensive knowledge of our business, his role since 1992 as our principal executive officer, and his corporate vision, operational knowledge and his strategic guidance to the Board.
What is the salary of George LeMaitre?
As the Chairman of the Board és Chief Executive Officer of Lemaitre Vascular Inc, the total compensation of George LeMaitre at Lemaitre Vascular Inc is $1,397,740. There are no executives at Lemaitre Vascular Inc getting paid more.
How old is George LeMaitre?
George LeMaitre is 55, he's been the Chairman of the Board és Chief Executive Officer of Lemaitre Vascular Inc since 2007. There are 8 older and 19 younger executives at Lemaitre Vascular Inc. The oldest executive at Lemaitre Vascular Inc is Dr. George D. LeMaitre, 87, who is the Founder and Chairman of Scientific Advisory Board.
What's George LeMaitre's mailing address?
George's mailing address filed with the SEC is C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON, MA, 01803.
Insiders trading at Lemaitre Vascular Inc
Over the last 18 years, insiders at Lemaitre Vascular Inc have traded over $169,251,022 worth of Lemaitre Vascular Inc stock and bought 22,755 units worth $292,783 . The most active insiders traders include George W Le Maitre, Guido J Neels és David B Roberts. On average, Lemaitre Vascular Inc executives and independent directors trade stock every 10 days with the average trade being worth of $1,488,890. The most recent stock trade was executed by David B Roberts on 13 August 2024, trading 3,063 units of LMAT stock currently worth $107,236.
What does Lemaitre Vascular Inc do?
lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.
What does Lemaitre Vascular Inc's logo look like?
Complete history of Mr. Maitre stock trades at Lemaitre Vascular Inc
Lemaitre Vascular Inc executives and stock owners
Lemaitre Vascular Inc executives and other stock owners filed with the SEC include:
-
George LeMaitre,
Chairman of the Board, Chief Executive Officer -
David Roberts,
President, Director -
Joseph Pellegrino,
Chief Financial Officer, Director -
George W. LeMaitre,
Chairman & CEO -
Trent Kamke,
Senior Vice President - Operations -
David B. Roberts,
Pres & Director -
Joseph P. Pellegrino Jr.,
CFO, Treasurer, Sec. & Director -
Trent G. Kamke,
Sr. VP of Operations -
John O'Connor,
Independent Director -
Lawrence Jasinski,
Independent Director -
John Roush,
Independent Director -
Bridget Ross,
Independent Director -
James Russell,
Director, Operations -
Helen Goulding,
Director, Sales - Northern Europe -
Ryan Connelly,
Vice President - Research & Development -
Xiang Zhang,
Vice President, Regulatory Affairs -
Jacob Petersen,
Vice President, Asia-Pac -
Jonathan Ngau,
Vice President - Information Technology -
Roli Kumar-Choudhury,
Vice President, Quality Affairs -
Kimberly Cieslak,
Vice President - Marketing -
Chance Kriesel,
Vice President - Sales, The Americas -
Giovannella Deiure,
Vice President, Sales – Southern Europe -
Stephane Maier,
Vice President, EMEA Operations -
Andrew Hodgkinson,
Senior Vice President - Clinical, Regulatory and Quality Affairs -
Laurie Churchill,
Senior Vice President, General Counsel -
Stephane Maier,
Sr. VP of EMEA Operations -
Andrew Hodgkinson,
Sr. VP of Clinical, Regulatory & Quality Affairs -
Daniel J. Mumford,
Director of HR -
Kimberly L. Cieslak,
VP of Marketing -
Laurie A. Churchill,
Sr. VP & Gen. Counsel -
Dr. George D. LeMaitre,
Founder and Chairman of Scientific Advisory Board -
Cornelia W Le Maitre,
V.P., Human Resources,Director -
Michael T Wijas,
VP of Sales, The Americas -
Michael H Thomas,
Director -
Russell D Hays,
Director -
Aaron M Grossman,
General Counsel -
William N Jr Thorndike,
Director -
Equity Investors Lp/Ma Hous...,
-
George D Le Maitre,
Director -
Michael C Jackson,
Director -
Robert V Linden,
VP, North American Sales -
Peter R Gebauer,
President, International OP -
Kevin D Kelly,
V. P. North American Sales -
Maik D Helmers,
V.P. Central European Sales -
Guido J Neels,
Director -
David N Gill,
Director -
Duane M De Sisto,
Director -
Martha Shadan,
Director